Index
RUT
Market Cap
2.57B
Enterprise Value
3.17B
Income
-56.12M
Sales
883.99M
Book/sh
9.56
Cash/sh
0.79
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
2636
IPO
Aug 23, 1989
P/E
-
Forward P/E
26.53
PEG
1.14
P/S
2.90
P/B
1.23
P/C
14.93
P/FCF
51.60
EV/EBITDA
26.94
EV/Sales
3.59
Quick Ratio
2.92
Current Ratio
3.90
Debt/Eq
0.37
LT Debt/Eq
0.37
Option/Short
Yes / Yes
EPS (ttm)
-0.26
EPS next Y
0.44
EPS next Q
0.06
EPS this Y
4.17%
EPS next Y
33.00%
EPS next 5Y
23.31%
EPS past 3/5Y
33.08% -
Sales past 3/5Y
1.91% 13.19%
EPS Y/Y TTM
94.64%
Sales Y/Y TTM
-0.33%
EPS Q/Q
-132.66%
Sales Q/Q
6.51%
Insider Own
0.99%
Insider Trans
-0.38%
Inst Own
109.97%
Inst Trans
2.68%
ROA
-1.68%
ROE
-2.67%
ROIC
-1.96%
Gross Margin
37.01%
Oper. Margin
0.01%
Profit Margin
-6.35%
SMA20
-1.98%
SMA50
-3.99%
SMA200
12.22%
Trades
Shs Outstand
218.30M
Shs Float
216.15M
52W High
14.26 -17.53%
52W Low
5.37 118.99%
Volatility
5.13% 4.20%
ATR (14)
0.57
RSI (14)
45.48
Beta
1.84
Rel Volume
0.73
Avg Volume
3.30M
Volume
2,408,428
Perf Week
-0.51%
Perf Month
0.43%
Perf Quarter
3.16%
Perf Half Y
29.94%
Perf YTD
68.24%
Perf Year
96.66%
Perf 3Y
-25.66%
Perf 5Y
-74.06%
Perf 10Y
-40.57%
Prev Close
11.68
Price
11.76
Change %
0.68%
Analysts 7 incl. previous ratings
Rating Distribution 3 Buy · 4 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Aug 26, 2026 Upgrade P Piper Sandler
Neutral → Overweight $14 +19.0% Jul 29, 2025 Downgrade W William Blair
Outperform → Mkt Perform Dec 19, 2024 Initiated G Guggenheim
Buy $15 +27.6% Jun 16, 2023 Initiated W Wells Fargo
Overweight $22 +87.1% Nov 22, 2022 Upgrade W William Blair
Mkt Perform → Outperform Jul 12, 2022 Initiated P Piper Sandler
Neutral $25 +112.6% May 23, 2019 Initiated G Guggenheim
Neutral Dec 05, 2017 Resumed R ROTH Capital
Neutral $82 +597.3% Jul 14, 2017 Initiated C CL King
Neutral Jun 05, 2014 Initiated W William Blair
Mkt Perform Mar 31, 2011 Upgrade H Hilliard Lyons
Underperform → Neutral Sep 25, 2009 Reiterated R Roth Capital
Buy $33 → $36 +206.1% Jul 22, 2009 Reiterated R Roth Capital
Buy $29 → $33 +180.6% Mar 20, 2009 Reiterated R Roth Capital
Buy $32 → $28 +138.1% Jan 07, 2009 Reiterated R Roth Capital
Buy $33 → $32 +172.1% Sep 25, 2008 Reiterated R Roth Capital
Buy $30 → $33 +180.6% Jan 04, 2008 Reiterated R Roth Capital
Buy $28 → $30 +155.1% Sep 28, 2007 Reiterated R Roth Capital
Buy $23.33 → $28 +138.1% Jul 25, 2007 Reiterated R Roth Capital
Buy $33 → $35 +197.6% Jul 09, 2007 Reiterated R Roth Capital
Buy $27 → $33 +180.6%
Show Previous Ratings
Nov-03-26 07:45AM
Oct-07-26 06:33PM
11:04AM
09:34AM
08:07AM
(Investor's Business Daily)
04:39PM
Loading…
Oct-06-26 04:39PM
04:10PM
04:01PM
08:45AM
04:30AM
03:36AM
Oct-02-26 08:02AM
(Investor's Business Daily)
Sep-15-26 04:30PM
Sep-08-26 09:00AM
Aug-26-26 09:41AM
03:03PM
Loading…
Jul-30-26 03:03PM
07:43AM
07:00AM
Jul-20-26 07:00AM
Jun-18-26 08:45AM
Apr-23-26 08:45AM
Apr-09-26 03:00PM
08:24AM
07:11AM
07:00AM
05:05AM
04:11AM
Apr-08-26 08:00AM
Mar-30-26 08:00AM
Mar-02-26 07:00AM
07:00AM
Loading…
07:00AM
Feb-25-26 09:54AM
Feb-23-26 10:55AM
Feb-02-26 07:33PM
Jan-29-26 12:34PM
Jan-28-26 06:27PM
Jan-15-26 12:31AM
Jan-12-26 07:45AM
Jan-09-26 09:49AM
12:30AM
Jan-08-26 10:30PM
07:24PM
06:00PM
04:53PM
03:29PM
02:25PM
02:00PM
01:09PM
11:35AM
10:44AM
07:30AM
07:15AM
07:09AM
(Associated Press Finance)
07:00AM
05:45AM
05:12AM
Jan-06-26 10:02PM
Jan-05-26 08:45AM
Jan-04-26 11:40PM
Dec-19-25 09:30AM
Dec-18-25 11:02PM
09:00AM
Dec-17-25 04:15PM
Dec-16-25 11:26AM
Dec-10-25 08:34AM
Dec-04-25 12:46PM
Dec-03-25 11:37PM
Nov-14-25 11:30AM
Nov-04-25 10:34PM
08:01PM
09:55AM
Oct-30-25 08:45AM
Oct-16-25 01:31AM
Oct-10-25 08:39AM
01:30AM
Oct-09-25 05:00PM
12:05PM
08:15AM
07:44AM
07:25AM
07:10AM
(Associated Press Finance)
07:00AM
05:23AM
04:30AM
Oct-07-25 11:00PM
Oct-06-25 09:15AM
Oct-02-25 02:39PM
10:00AM
Oct-01-25 12:03AM
Sep-30-25 12:51PM
Sep-25-25 05:26PM
Sep-24-25 09:06AM
Sep-18-25 04:15PM
Sep-17-25 09:00AM
Sep-16-25 11:40AM
Sep-15-25 04:01PM
Sep-11-25 03:55PM
Sep-03-25 05:02PM
Aug-27-25 10:00AM
Aug-25-25 09:17AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Yarwood Jeremy Chief Scientific Officer Nov 03 '26 Option Exercise 11.82 16,207 191,567 16,207 Nov 04 04:10 PM Yarwood Jeremy Chief Scientific Officer Nov 04 '26 Sale 12.67 9,051 114,676 0 Nov 04 04:10 PM Yarwood Jeremy Officer Nov 04 '26 Proposed Sale 12.67 9,051 114,637 Nov 04 11:23 AM Hastings Gregory S VP, Animal Health Oct 29 '26 Option Exercise 12.21 1,211 14,786 33,786 Oct 30 03:33 PM Woteki Catherine E Director Oct 29 '26 Option Exercise 12.21 1,776 21,685 29,507 Oct 30 03:08 PM RODRIGUEZ RAFAEL A Director Oct 29 '26 Option Exercise 12.21 1,776 21,685 31,211 Oct 30 02:45 PM Gupta Aashima Director Oct 29 '26 Option Exercise 12.21 1,776 21,685 38,180 Oct 30 06:47 AM Green Ronald D Director Oct 29 '26 Option Exercise 12.21 1,776 21,685 29,044 Oct 30 06:43 AM CAPELLO JEFFREY D Director Oct 29 '26 Option Exercise 12.21 1,776 21,685 42,892 Oct 30 06:39 AM BOREL JAMES C Director Oct 29 '26 Option Exercise 12.21 1,776 21,685 106,737 Oct 30 06:34 AM Bernard Thierry Former Director Oct 28 '26 Proposed Sale 12.19 16,937 206,521 Oct 28 03:01 PM Hastings Gregory S VP, Animal Health Oct 14 '26 Option Exercise 12.00 287 3,444 32,655 Oct 23 06:55 AM Nassif Mikheal CEO Oct 09 '26 Buy 11.95 505 6,035 1,579 Oct 09 07:24 PM Nassif Mikheal CEO Aug 04 '26 Buy 11.81 370 4,370 1,074 Aug 06 08:16 AM Rocklin Amy M Former Officer Jun 03 '26 Proposed Sale 8.79 30,337 266,559 Jun 03 03:15 PM Rocklin Amy M Former Officer May 29 '26 Proposed Sale 9.18 87,681 805,154 May 29 02:20 PM Rocklin Amy M Former Chief Legal Officer May 18 '26 Option Exercise 9.29 35,183 326,850 92,423 May 19 08:37 AM Moylan John Patrick Chief Accounting Officer May 04 '26 Option Exercise 9.53 4,558 43,438 18,905 May 05 10:06 AM Nassif Mikheal CEO Feb 17 '26 Buy 10.94 23 252 704 Feb 17 03:12 PM Nassif Mikheal CEO Jan 26 '26 Buy 9.86 25 246 657 Feb 02 04:36 PM Nassif Mikheal CEO Feb 02 '26 Buy 10.00 24 240 681 Feb 02 04:36 PM Nassif Mikheal CEO Jan 16 '26 Buy 9.33 137 1,279 632 Jan 16 09:04 AM Naemura David H. Former CFO Dec 01 '25 Option Exercise 5.98 12,912 77,214 93,936 Dec 02 11:45 AM
Neogen Corp. engages in the provision of development, manufacture, and marketing of food and animal safety products. It operates through the Food Safety and Animal Safety segments. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.
CEO Mr. Mikhael Nassif
CFO & Senior Vice President Mr. R. Bryan Riggsbee CPA
J.D. Ms. Jennifer Evans Stacey Esq.
Senior VP & GM of Global Food Safety Dr. Tamara A. Ranalli Ph.D.
VP Mr. John Moylan